Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Micro Systems Technologies (MST) is a leading international group of technology companies that provides innovative components and services for the medical device industry, specifically focusing on active implants. The group specializes in the miniaturization of electronics, offering high-end printed circuit boards, microassemblies, and specialized primary batteries for life-sustaining devices. MST serves global original equipment manufacturers (OEMs) in critical fields such as cardiac rhythm management, neuromodulation, and cochlear implants. Their expertise covers the entire product lifecycle, from initial design and process development to high-volume, high-reliability manufacturing. Headquartered in Switzerland, the group operates several specialized production facilities across Europe and the United States. In 2024, the company was acquired by KKR, highlighting its strategic importance in the global MedTech supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Micro Systems Technologies.